GPR183 and myeloid sarcoma: The increased CH25H and EBI2 transcripts inside MS plaques confirm and expend previous reports of increased EBI2 in the plaques in infiltrating lymphocytes (Wanke et al., 2017) and in glial cells (Klejbor et al., 2021).